Connecting the
Diabetes, Obesity, Metabolism and Complications Community
at Michigan
|
|
Welcome to the July 2020 issue of Dialogue!
MDiabetes is now the Elizabeth Weiser Caswell Diabetes Institute
The
Elizabeth Weiser Caswell Diabetes Institute
supplants the Michigan Diabetes Center (MDiabetes), and will continue to be led by Director Martin G. Myers, Jr., M.D., Ph.D. and Managing Director, Dorene S. Markel, M.S., M.H.S.A. Learn more about the gift that establishes the new institute
here
.
If you have news items or events of interest to the
diabetes, obesity, metabolism and complications
community at Michigan, please tell us. Also, we welcome all input and suggestions -- let us know what you think we should be doing. Email us at
MichiganDiabetes@med.umich.edu
or call 734-764-4433.
|
|
Steno North American Fellowships
is a transatlantic collaboration in clinical and health outcomes diabetes-related research, enhancing the synergies between the institutions for the benefit of people suffering from diabetes.
The fellowship offers researchers, affiliated with one of the partnering institutions, the opportunity to dedicate from 3 months to 1.5 years to practice clinical and health outcomes diabetes-related research at one of the other transatlantic partner institutions mentioned above.
|
|
Preventing Early Renal Loss in Diabetes (PERL) Study Published in the
New England Journal of Medicine
(
NEJM
)
|
Promising treatment to slow kidney disease doesn’t prove out in clinical trial
Scientists find that reducing levels of uric acid in the blood does not guard against complication in patients with type 1 diabetes.
Historically, half or more of people with type 1 diabetes develop kidney disease, which frequently progresses to kidney failure requiring hemodialysis or a kidney transplant for survival. This high rate of this diabetic complication has dropped slightly in recent years, with the advent of better ways to control blood glucose (sugar) levels and better blood pressure control, including blood pressure drugs that block the renin-angiotensin system, “but diabetic kidney disease remains a huge problem,” says Rodica Pop-Busui, MD, PhD.
|
|
|
|
MDiabetes COVID-19 and Metabolic Disease Grant Program Award
|
The ongoing COVID-19 pandemic poses an enormous number of challenges, many of them disproportionately affecting those with diabetes, obesity, and related conditions. To understand and begin to alleviate the impact of COVID-19 on those with diabetes and related disorders, the MDiabetes COVID-19 and Metabolic Disease Grant Program was established to address the impact of COVID-19 on and improve the care of those with diabetes and related disorders.
Congratulations to Dr. Terrance Wong, whose proposal entitled “
Impact of Clonal Hematopoiesis on COVID-19 Morbidity and Mortality
” was selected for funding. Dr. Wong’s research focuses on understanding how alterations in the immune system defined by clonal hematopoiesis contribute to the cytokine storm and poor prognosis of people with diabetes and metabolic syndrome during COVID-19.
|
|
A Wife and Mother Turned Diabetes Research Crusader
When Elizabeth Weiser Caswell had two of three sons diagnosed with type 1 diabetes, she became relentless in her pursuit of more diabetes research, education and a cure. Now, her family is giving a $30 million gift to U-M in her honor.
|
|
|
|
|
Medicine Grand Rounds
Roma Gianchandani, MD
Rodica Pop-Busui, MD, PhD
Brian Schmidt, DPM
12:00 p.m.
|
|
|
|
Hudson Mills Metropark, Dexter
|
|
For a full list of events go to the Elizabeth Weiser Caswell Diabetes Institute
Calendar of Events
Email us
to subscribe to our weekly Event Roundup email
|
|
|
|
Michigan Diabetes Research Center 2020-21 Regional Pilot/Feasibility Grant Program
Deadline: August 5, 2020
|
|
|
|
Michigan Diabetes Research Center 2020-21 Pilot/Feasibility Grant Program
Deadline: August 5, 2020
|
|
|
|
Michigan Diabetes Research Center 2020-21 Diabetes Interdisciplinary Study Program
Deadline: August 5, 2020
|
|
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship
|
|
Visit the Michigan Medical School
Competition Space
for more funding opportunities at the Medical School
|
|
About the Elizabeth Weiser Caswell Diabetes Institute
The University of Michigan has outstanding clinicians and researchers in diabetes, metabolic disorders, and their complications. The Elizabeth Weiser Caswell Diabetes Institute serves as the central hub to coordinate these programs. We work across disciplines and serve to integrate rigorous science with patient-centered clinical care to prevent, treat, and ultimately cure diabetes and related disorders.
|
|
Contact Us
Elizabeth Weiser Caswell Diabetes Institute
300 North Ingalls Building, Room 1135
Ann Arbor, Michigan 48109-5405
734-764-4433
Stay Informed
Did you receive this newsletter from a friend?
Email us at
to be added to our mailing list.
|
|
|
Supporting the Elizabeth Weiser Caswell Diabetes Institute
|
|
Gifts to t
he Elizabeth Weiser Caswell Diabetes Institute
are essential to our mission, to be at the forefront of cutting-edge research and to educate the next generation of leaders to be the best in medicine. Please consider supporting
t
he Elizabeth Weiser Caswell Diabetes Institute
: gifts can be made through multiple vehicles such as cash or securities, pledges, payroll deduct, etc. Our development partner, Andrea LaFave is happy to discuss and explore different options with you.
|
|
|
|
|
|
|
